{"id":"e03ba739-db71-48b6-a699-00cfdc475b5f","kind":"companies","code":"UB-C9396","name":"Encoded Therapeutics","nameBasis":"source-english","summary":"","description":"","country":null,"category":null,"originalName":"Encoded Therapeutics","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-12T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.865Z","reviewedAt":"2026-10-20T18:26:36.865Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"f032367c8bcc247a3b94dd73fb97c5e40b62cbba1b040de557efc689bb7ffd0a","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"0d7b132c-9f7f-4cb7-af67-27dfe1d59199","kind":"institutions","code":"UB-I2761","name":"ARCH","nameBasis":"original-brand","summary":"ARCH, a venture capital firm focused on technology investments.","description":"ARCH, a venture capital firm focused on technology investments.","country":"United States","category":null,"originalName":"ARCH","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.747Z","englishUpdatedAt":"2026-10-20T18:26:49.254Z","reviewedAt":"2026-10-20T18:26:49.254Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"baa62662f3f1a13197198fdfa135dc186a7f8adf4230c9f92732673b6dd1626c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch"},{"id":"851b5196-d17d-49a8-86c3-14a0de5ce635","kind":"institutions","code":"UB-I2715","name":"Braidwell","nameBasis":"original-brand","summary":"Braidwell, a venture capital firm focused on medical investments.","description":"Braidwell, a venture capital firm focused on medical investments.","country":"United States","category":null,"originalName":"Braidwell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.340Z","englishUpdatedAt":"2026-10-20T18:26:56.917Z","reviewedAt":"2026-10-20T18:26:56.917Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"0b1112314920c79a24a462918ff0f9c2eb5c6513f5fa3d186ada29b52cfc218a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/braidwell"},{"id":"1b8fb32f-9c3e-4849-af7e-66ed4e9e0347","kind":"products","code":"UB-D6229","name":"Encoded Therapeutics","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"Encoded Therapeutics","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-13T16:58:04.219Z","englishUpdatedAt":"2026-10-20T18:28:54.529Z","reviewedAt":"2026-10-20T18:28:54.529Z","snapshotAt":"2026-10-20T18:06:34.551Z","sourceHash":"80b166a1bda4dcbebef7f836a8af0e43d160f4ae7cf598427db0434c1c03b15e","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/products/encoded-therapeutics"},{"id":"0769c607-bd70-42e1-b9c8-2d310064fa23","kind":"news","code":"0769c607-bd70-42e1-b9c8-2d310064fa23","name":"Encoded Therapeutics Raises $275M Series F for Gene Therapies","nameBasis":"translated-title","summary":"On September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela.","description":"","country":null,"category":null,"originalName":"Encoded Therapeutics完成2.75亿美元F轮融资，推进基因疗法","eventDate":"2026-09-09T00:00:00.000Z","website":"https://encoded.com/encoded-therapeutics-raises-275-million-in-series-f-financing-to-advance-etx101-","sourceUpdatedAt":"2026-10-16T18:48:17.342Z","englishUpdatedAt":"2026-10-20T18:21:32.462Z","reviewedAt":"2026-10-20T18:21:32.462Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"d7397a1d0048b141d7f2f1c00be322b91139d13a2cbe8cc280786e5345896c29","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/news/0769c607-bd70-42e1-b9c8-2d310064fa23"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"2a6edf92-ab1a-49f1-8ecf-b52013bd51f8","kind":"people","code":"UB-P1629","name":"Kartik Ramamoorthi","nameBasis":"original-brand","summary":"Founder","description":"","country":null,"category":null,"originalName":"Kartik Ramamoorthi","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-17T15:26:03.543Z","englishUpdatedAt":"2026-10-20T18:27:15.375Z","reviewedAt":"2026-10-20T18:27:15.375Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"2316eb0e6cde0c46eee93223811c737af4a0648810144f261ba25e2e52175943","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/people/kartik-ramamoorthi"},{"id":"d66124d5-8602-4f3d-9014-6881c14ad85b","kind":"people","code":"UB-P1680","name":"Stephanie Tagliatela","nameBasis":"original-brand","summary":"Founder","description":"","country":null,"category":null,"originalName":"Stephanie Tagliatela","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-17T15:26:03.628Z","englishUpdatedAt":"2026-10-20T18:28:46.822Z","reviewedAt":"2026-10-20T18:28:46.822Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"9db2e16108c2fb70b724cee36641e550a7799b0914e698d6d320b2bdfd3c00ff","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/people/stephanie-tagliatela"},{"id":"71b33918-03e7-4abe-821b-a87091b5543c","kind":"institutions","code":"UB-I184","name":"软银愿景基金二期","nameBasis":"transliterated","summary":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","description":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","country":"Japan","category":null,"originalName":"软银愿景基金二期","eventDate":null,"website":"https://visionfund.com/","sourceUpdatedAt":"2026-10-18T22:00:13.736Z","englishUpdatedAt":"2026-10-20T18:26:56.700Z","reviewedAt":"2026-10-20T18:26:56.700Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8bff6e030450f3ca091d956b27cbd239db2c2663f000a3921ae7df89c4c91e5f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruanyinyuanjing Fund Phase Two","path":"/institutions/ruanyinyuanjing-fund-phase-two"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":275000000,"text":"2.75亿美元","date":"2026-09-09T00:00:00.000Z","round":"Series F","estimate":"$275M"},"years":[2026],"points":[{"year":2026,"date":"2026-09-09T00:00:00.000Z","round":"Series F","value":275000000,"eventIds":["0769c607-bd70-42e1-b9c8-2d310064fa23"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"0769c607-bd70-42e1-b9c8-2d310064fa23","date":"2026-09-09T00:00:00.000Z","round":"Series F","amountText":"2.75亿美元","estimateUsd":275000000,"estimateLabel":"$275M","estimateNote":null,"investors":"GV及另一家未具名医疗健康基金（共同领投）、ARCH、Braidwell、Illumina Ventures、SoftBank Vision Fund 2","institutions":[{"id":"0d7b132c-9f7f-4cb7-af67-27dfe1d59199","kind":"institutions","code":"UB-I2761","name":"ARCH","nameBasis":"original-brand","summary":"ARCH, a venture capital firm focused on technology investments.","description":"ARCH, a venture capital firm focused on technology investments.","country":"United States","category":null,"originalName":"ARCH","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.747Z","englishUpdatedAt":"2026-10-20T18:26:49.254Z","reviewedAt":"2026-10-20T18:26:49.254Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"baa62662f3f1a13197198fdfa135dc186a7f8adf4230c9f92732673b6dd1626c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch"},{"id":"851b5196-d17d-49a8-86c3-14a0de5ce635","kind":"institutions","code":"UB-I2715","name":"Braidwell","nameBasis":"original-brand","summary":"Braidwell, a venture capital firm focused on medical investments.","description":"Braidwell, a venture capital firm focused on medical investments.","country":"United States","category":null,"originalName":"Braidwell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.340Z","englishUpdatedAt":"2026-10-20T18:26:56.917Z","reviewedAt":"2026-10-20T18:26:56.917Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"0b1112314920c79a24a462918ff0f9c2eb5c6513f5fa3d186ada29b52cfc218a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/braidwell"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"71b33918-03e7-4abe-821b-a87091b5543c","kind":"institutions","code":"UB-I184","name":"软银愿景基金二期","nameBasis":"transliterated","summary":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","description":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","country":"Japan","category":null,"originalName":"软银愿景基金二期","eventDate":null,"website":"https://visionfund.com/","sourceUpdatedAt":"2026-10-18T22:00:13.736Z","englishUpdatedAt":"2026-10-20T18:26:56.700Z","reviewedAt":"2026-10-20T18:26:56.700Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8bff6e030450f3ca091d956b27cbd239db2c2663f000a3921ae7df89c4c91e5f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruanyinyuanjing Fund Phase Two","path":"/institutions/ruanyinyuanjing-fund-phase-two"}],"newsUrl":"https://encoded.com/encoded-therapeutics-raises-275-million-in-series-f-financing-to-advance-etx101-","evidence":{"headline":"Encoded Therapeutics Raises $275M Series F for Gene Therapies","brief":"On September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela.","basis":"translated-source-brief","newsPath":"/news/0769c607-bd70-42e1-b9c8-2d310064fa23","sourceCount":1}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"0769c607-bd70-42e1-b9c8-2d310064fa23","date":"2026-09-09T00:00:00.000Z","round":"Series F","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"GV及另一家未具名医疗健康基金（共同领投）、ARCH、Braidwell、Illumina Ventures、SoftBank Vision Fund 2","institutions":[{"id":"0d7b132c-9f7f-4cb7-af67-27dfe1d59199","kind":"institutions","code":"UB-I2761","name":"ARCH","nameBasis":"original-brand","summary":"ARCH, a venture capital firm focused on technology investments.","description":"ARCH, a venture capital firm focused on technology investments.","country":"United States","category":null,"originalName":"ARCH","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.747Z","englishUpdatedAt":"2026-10-20T18:26:49.254Z","reviewedAt":"2026-10-20T18:26:49.254Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"baa62662f3f1a13197198fdfa135dc186a7f8adf4230c9f92732673b6dd1626c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch"},{"id":"851b5196-d17d-49a8-86c3-14a0de5ce635","kind":"institutions","code":"UB-I2715","name":"Braidwell","nameBasis":"original-brand","summary":"Braidwell, a venture capital firm focused on medical investments.","description":"Braidwell, a venture capital firm focused on medical investments.","country":"United States","category":null,"originalName":"Braidwell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.340Z","englishUpdatedAt":"2026-10-20T18:26:56.917Z","reviewedAt":"2026-10-20T18:26:56.917Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"0b1112314920c79a24a462918ff0f9c2eb5c6513f5fa3d186ada29b52cfc218a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/braidwell"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"71b33918-03e7-4abe-821b-a87091b5543c","kind":"institutions","code":"UB-I184","name":"软银愿景基金二期","nameBasis":"transliterated","summary":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","description":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","country":"Japan","category":null,"originalName":"软银愿景基金二期","eventDate":null,"website":"https://visionfund.com/","sourceUpdatedAt":"2026-10-18T22:00:13.736Z","englishUpdatedAt":"2026-10-20T18:26:56.700Z","reviewedAt":"2026-10-20T18:26:56.700Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8bff6e030450f3ca091d956b27cbd239db2c2663f000a3921ae7df89c4c91e5f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruanyinyuanjing Fund Phase Two","path":"/institutions/ruanyinyuanjing-fund-phase-two"}],"newsUrl":"https://encoded.com/encoded-therapeutics-raises-275-million-in-series-f-financing-to-advance-etx101-","evidence":{"headline":"Encoded Therapeutics Raises $275M Series F for Gene Therapies","brief":"On September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela.","basis":"translated-source-brief","newsPath":"/news/0769c607-bd70-42e1-b9c8-2d310064fa23","sourceCount":1}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"0769c607-bd70-42e1-b9c8-2d310064fa23","kind":"funding","eventDate":"2026-09-09T00:00:00.000Z","revenueDate":null,"round":"F轮","amountText":"2.75亿美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":275000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"GV及另一家未具名医疗健康基金（共同领投）、ARCH、Braidwell、Illumina Ventures、SoftBank Vision Fund 2","newsUrl":"https://encoded.com/encoded-therapeutics-raises-275-million-in-series-f-financing-to-advance-etx101-","newsTypes":["融资"],"institutions":[{"id":"0d7b132c-9f7f-4cb7-af67-27dfe1d59199","kind":"institutions","code":"UB-I2761","name":"ARCH","nameBasis":"original-brand","summary":"ARCH, a venture capital firm focused on technology investments.","description":"ARCH, a venture capital firm focused on technology investments.","country":"United States","category":null,"originalName":"ARCH","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.747Z","englishUpdatedAt":"2026-10-20T18:26:49.254Z","reviewedAt":"2026-10-20T18:26:49.254Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"baa62662f3f1a13197198fdfa135dc186a7f8adf4230c9f92732673b6dd1626c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch"},{"id":"851b5196-d17d-49a8-86c3-14a0de5ce635","kind":"institutions","code":"UB-I2715","name":"Braidwell","nameBasis":"original-brand","summary":"Braidwell, a venture capital firm focused on medical investments.","description":"Braidwell, a venture capital firm focused on medical investments.","country":"United States","category":null,"originalName":"Braidwell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.340Z","englishUpdatedAt":"2026-10-20T18:26:56.917Z","reviewedAt":"2026-10-20T18:26:56.917Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"0b1112314920c79a24a462918ff0f9c2eb5c6513f5fa3d186ada29b52cfc218a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/braidwell"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"71b33918-03e7-4abe-821b-a87091b5543c","kind":"institutions","code":"UB-I184","name":"软银愿景基金二期","nameBasis":"transliterated","summary":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","description":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","country":"Japan","category":null,"originalName":"软银愿景基金二期","eventDate":null,"website":"https://visionfund.com/","sourceUpdatedAt":"2026-10-18T22:00:13.736Z","englishUpdatedAt":"2026-10-20T18:26:56.700Z","reviewedAt":"2026-10-20T18:26:56.700Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8bff6e030450f3ca091d956b27cbd239db2c2663f000a3921ae7df89c4c91e5f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruanyinyuanjing Fund Phase Two","path":"/institutions/ruanyinyuanjing-fund-phase-two"}],"roundName":"Series F","amountLabel":"$275M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"2a6edf92-ab1a-49f1-8ecf-b52013bd51f8","kind":"people","code":"UB-P1629","name":"Kartik Ramamoorthi","nameBasis":"original-brand","summary":"Founder","description":"","country":null,"category":null,"originalName":"Kartik Ramamoorthi","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-17T15:26:03.543Z","englishUpdatedAt":"2026-10-20T18:27:15.375Z","reviewedAt":"2026-10-20T18:27:15.375Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"2316eb0e6cde0c46eee93223811c737af4a0648810144f261ba25e2e52175943","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/people/kartik-ramamoorthi"},{"id":"d66124d5-8602-4f3d-9014-6881c14ad85b","kind":"people","code":"UB-P1680","name":"Stephanie Tagliatela","nameBasis":"original-brand","summary":"Founder","description":"","country":null,"category":null,"originalName":"Stephanie Tagliatela","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-17T15:26:03.628Z","englishUpdatedAt":"2026-10-20T18:28:46.822Z","reviewedAt":"2026-10-20T18:28:46.822Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"9db2e16108c2fb70b724cee36641e550a7799b0914e698d6d320b2bdfd3c00ff","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/people/stephanie-tagliatela"}],"productsRelated":[{"id":"1b8fb32f-9c3e-4849-af7e-66ed4e9e0347","kind":"products","code":"UB-D6229","name":"Encoded Therapeutics","nameBasis":"original-brand","summary":"","description":"","country":null,"category":null,"originalName":"Encoded Therapeutics","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-13T16:58:04.219Z","englishUpdatedAt":"2026-10-20T18:28:54.529Z","reviewedAt":"2026-10-20T18:28:54.529Z","snapshotAt":"2026-10-20T18:06:34.551Z","sourceHash":"80b166a1bda4dcbebef7f836a8af0e43d160f4ae7cf598427db0434c1c03b15e","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"path":"/products/encoded-therapeutics"}],"investors":[{"id":"0d7b132c-9f7f-4cb7-af67-27dfe1d59199","kind":"institutions","code":"UB-I2761","name":"ARCH","nameBasis":"original-brand","summary":"ARCH, a venture capital firm focused on technology investments.","description":"ARCH, a venture capital firm focused on technology investments.","country":"United States","category":null,"originalName":"ARCH","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.747Z","englishUpdatedAt":"2026-10-20T18:26:49.254Z","reviewedAt":"2026-10-20T18:26:49.254Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"baa62662f3f1a13197198fdfa135dc186a7f8adf4230c9f92732673b6dd1626c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch"},{"id":"851b5196-d17d-49a8-86c3-14a0de5ce635","kind":"institutions","code":"UB-I2715","name":"Braidwell","nameBasis":"original-brand","summary":"Braidwell, a venture capital firm focused on medical investments.","description":"Braidwell, a venture capital firm focused on medical investments.","country":"United States","category":null,"originalName":"Braidwell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.340Z","englishUpdatedAt":"2026-10-20T18:26:56.917Z","reviewedAt":"2026-10-20T18:26:56.917Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"0b1112314920c79a24a462918ff0f9c2eb5c6513f5fa3d186ada29b52cfc218a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/braidwell"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"71b33918-03e7-4abe-821b-a87091b5543c","kind":"institutions","code":"UB-I184","name":"软银愿景基金二期","nameBasis":"transliterated","summary":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","description":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","country":"Japan","category":null,"originalName":"软银愿景基金二期","eventDate":null,"website":"https://visionfund.com/","sourceUpdatedAt":"2026-10-18T22:00:13.736Z","englishUpdatedAt":"2026-10-20T18:26:56.700Z","reviewedAt":"2026-10-20T18:26:56.700Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8bff6e030450f3ca091d956b27cbd239db2c2663f000a3921ae7df89c4c91e5f","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Ruanyinyuanjing Fund Phase Two","path":"/institutions/ruanyinyuanjing-fund-phase-two"}],"path":"/companies/encoded-therapeutics","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":null},"definition":"Encoded Therapeutics is a company.","summaryBasis":null,"thin":false,"canonical":"https://uniquebase.ai/companies/encoded-therapeutics"}